News

Varenicline helps smokers with stably treated depression

View on the News

Trial may be helpful in understanding of non-psychiatrically ill smokers with history of depression

Dr. Vera DePalo

Dr. Vera DePalo, FCCP, comments: Smoking is a habit that contributes to several disease states and many strategies are employed to help with smoking cessation. Practitioners continue to search for the intervention that can aid the patient in success. As with all pharmacologic therapies,the prescriber considers the unintended side effects.
This industry-funded trial may be helpful to the practitioner's understanding of the possible options in non-psychiatrically ill smokers with a history of depression.


 

FROM ANNALS OF INTERNAL MEDICINE

*CORRECTION, 10/10/13: An earlier version of this article misstated the citation for the journal article referenced in the story.

Pages

Recommended Reading

Three Weight-Loss Diets Yield Three Metabolic Effects
MDedge Endocrinology
Tailored Weight-Loss Programs May Save Money
MDedge Endocrinology
Integrative care is the future of psychiatric care
MDedge Endocrinology
Link between depression, medical comorbidities underscores need for screening
MDedge Endocrinology
Behavioral weight-loss intervention works for patients with serious mental illness
MDedge Endocrinology
Vyvanse shows promise for binge-eating disorder
MDedge Endocrinology
Low-dose paroxetine approved for hot flashes
MDedge Endocrinology
Long-term depression may affect ability to conceive
MDedge Endocrinology
CRTC1 polymorphisms affect BMI, novel study finds
MDedge Endocrinology
Depression linked to accelerated cognitive decline in diabetes
MDedge Endocrinology